Picture of Collegium Pharmaceutical logo

COLL — Collegium Pharmaceutical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Collegium Pharmaceutical Inc reports results for the quarter ended in December - Earnings Summary

* Collegium Pharmaceutical Inc  COLL.OQ  reported quarterly
adjusted earnings of 82 cents​​ per share for the quarter ended
in December, higher than the same quarter last year, when the
company reported EPS of -21 cents.  The mean expectation of
six analysts for the quarter was for earnings of 66 cents per
share. Wall Street expected results to range from 60 cents to 72
cents per share.
    * Revenue rose 15.5% to $149.75 million from a year ago;
analysts
expected $147.82 million. 
    * Collegium Pharmaceutical Inc's reported EPS for the
quarter was
82 cents​.
    * The company reported quarterly net income of $31.94
million.
    * Collegium Pharmaceutical Inc shares had risen by 3.2% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 14.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is $38.00 
This summary was machine generated from LSEG data February 23 at
03:02 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.66           0.82           Beat
 Sep. 30 2023      0.52           0.53           Beat
 Jun. 30 2023      0.29           0.34           Beat
 Mar. 31 2023      0.31           -0.51          Missed

Recent news on Collegium Pharmaceutical

See all news